Skip to main content

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

Did you miss last night's "Mad Money" on CNBC? If so, here are Jim Cramer's top takeaways for today's trading.

Image placeholder title

Splunk (SPLK) - Get Free Report : In an exclusive interview, Cramer welcomed Doug Merritt, president and CEO of Splunk. When Splunk reported earnings in late May, the results were better than expected, with 48% year-over-year sales growth and 44% boost to free-cash flow. The company also raised its full-year outlook.

While these growth numbers will eventually slow, Merritt said there is still a "massive opportunity" out there, as companies' needs continue to grow. Splunk will aggressively continue to chase those opportunities.

He noted some customers are big names: Home Depot (HD) - Get Free Report and Domino's Pizza (DPZ) - Get Free Report . At first, these companies just wanted some basic services. But after working with Splunk and realizing the power of the analytics the company could provide, they became much closer partners.

This company is doing a great job and it's still early innings, Cramer said. Although it's unprofitable at the moment, growth remains highs.

Image placeholder title

Chipotle Mexican Grill (CMG) - Get Free Report : Shares of Chipotle have been hammered mercilessly since its E.coli outbreak last year. Shares are down 18% in 2016 and 35% over the past year, and hit a new 52-week low in Thursday's session.

This got Cramer's attention. It feels like there is a jinx on this stock and others that use natural and organic ingredients rather than heavily process foods. And while customers have tended to focus on the long-term benefits of consuming these natural ingredients, he's worried that in the short term, they could consider it more dangerous because of potential bacterial infections.

Although Chipotle seems to have become the "gold standard" in health safety since the incidents, consumers just don't seem to care, Cramer said. This is causing investors to forego paying a high premium for the stock, thus the underperformance.

So should you give up on the stock? "Absolutely not!" Cramer said, not if you're a long-term investor.

Image placeholder title

Henry Schein (HSIC) - Get Free Report : In a second interview, Cramer welcomed Stanley Bergman, chairman and CEO of Henry Schein, the largest distributor of dental and veterinary products and a big supplier of vaccines and medical devices.

The company continues to introduce new technologies to physicians, vets and dentists, and because of that, Henry Schein has become the go-to company for many of these healthcare providers, Bergman said.

Regarding some of that new technology, Bergman provided an example. Rather than going in for a crown and having a mold created from an impression, dentists can now digitally scan for the crown molding. Some dentists can even have the mold made right in the office, so patients go from having several visits, to just one.

When it comes to the Affordable Care Act, Bergman said the debate isn't whether preventive care is a good idea, it's who's paying for it. For Henry Schein's business, more Americans having access to health care bodes well for the company.

The stock is down too much from its recent highs, Cramer said, adding that its recent earnings report was good. "It's just a buy," he said.

To read a full recap of "Mad Money" on CNBC, click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had no position in stocks mentioned.